Mechanoregulating HA-integrated anisotropic fibrous vessel promote AKT-sensitive and YAP-associated endothelial responses and improve regional lymphatic drainage in lymphedema
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
References (61)
Show source-provided references
1. Risk factors affecting breast cancer-related lymphedema: serial body weight change during neoadjuvant anthracycline plus cyclophosphamide followed by taxane10.1016/j.clbc.2017.06.003 ↗
2. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection10.1177/000313480306900306 ↗
3. Lymphedema pathophysiology and clinical manifestations10.1016/j.jaad.2017.03.022 ↗
4. Lymphedema: pathogenesis and novel therapies10.1146/annurev-med-060116-022900 ↗
5. Surgical treatment of breast cancer-related lymphedema: an updated review
6. Hyaluronic acid in inflammation and tissue regeneration
7. Porous biomimetic hyaluronic acid and extracellular matrix protein nanofiber scaffolds for accelerated cutaneous tissue repair10.1021/acsami.9b17322 ↗
8. Hydrolysis of hyaluronic acid in lymphedematous tissue alleviates fibrogenesis via TH1 cell-mediated cytokine expression
9. Therapeutic effects of hyaluronidase on acquired lymphedema using a newly developed mouse limb model10.1177/1535370216688570 ↗
10. Hyaluronan as an immune regulator in human diseases10.1152/physrev.00052.2009 ↗
11. Hyaluronan fragments: an information-rich system10.1016/j.ejcb.2006.05.009 ↗
12. Small fragments of hyaluronan are increased in individuals with obesity and contribute to low-grade inflammation through TLR-mediated activation of innate immune cells10.1038/s41366-022-01187-z ↗
13. Lymphatic channel sheet of polydimethylsiloxane for preventing secondary lymphedema in the rat upper limb model10.1002/btm2.10371 ↗
14. Aligned nanofibrillar collagen scaffolds - guiding lymphangiogenesis for treatment of acquired lymphedema10.1016/j.biomaterials.2016.05.040 ↗
15. Recellularized lymph node scaffolds with human adipose-derived stem cells enhance lymph node regeneration to improve lymphedema
16. Lymphatic endothelial cell junctions: molecular regulation in physiology and diseases
17. Transmural flow modulates cell and fluid transport functions of lymphatic endothelium10.1161/CIRCRESAHA.109.207274 ↗
18. 3D electrospun synthetic extracellular matrix for tissue regeneration10.1002/smsc.202100003 ↗
19. Biofabrication methods for reconstructing extracellular matrix mimetics
20. Harnessing the coil electrospinning method for fabricating superflexible and multiscale-patterned fibrous tubular scaffolds with topographical features10.1021/acsami.4c03656 ↗
21. Integration of substrate- and flow-derived stresses in endothelial cell mechanobiology10.1038/s42003-021-02285-w ↗
22. Creating small diameter bioresorbable vascular grafts through electrospinning10.1039/B711848A ↗
23. Small-diameter vascular graft composing of core-shell structured micro-nanofibers loaded with heparin and VEGF for endothelialization and prevention of neointimal hyperplasia10.1016/j.biomaterials.2024.122507 ↗
24. Nanofiber electrospinning combined with rotary bioprinting for fabricating small-diameter vessels with endothelium and smooth muscle10.1016/j.compositesb.2022.109691 ↗
25. Aligned fibrous scaffolds promote directional migration of breast cancer cells caveolin-1/YAP-mediated mechanosensing10.1016/j.mtbio.2024.101245 ↗
26. Cellular spatial sensing determines cell mechanotransduction activity on the aligned nanofibers10.1002/smll.202410351 ↗
27. PIEZO1 and PECAM1 interact at cell-cell junctions and partner in endothelial force sensing10.1038/s42003-023-04706-4 ↗
28. Architecture of the mammalian mechanosensitive Piezo1 channel10.1038/nature15247 ↗
29. YAP and TAZ maintain PROX1 expression in the developing lymphatic and lymphovenous valves in response to VEGF-C signaling
30. Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms
31. Lymphatic vasculature development10.1038/nri1258 ↗
32. Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi10.1038/s41467-020-17886-y ↗
33. Lymph flow regulates collecting lymphatic vessel maturation in vivo10.1172/JCI79386 ↗
34. Hdac3 regulates lymphovenous and lymphatic valve formation10.1172/JCI92852 ↗
35. The lymphatic vasculature in disease10.1038/nm.2545 ↗
36. Development of Y-shaped small diameter artificial blood vessel with controlled topography via a modified electrospinning method10.1016/j.matlet.2019.127113 ↗
37. The controlled design of electrospun PCL/silk/quercetin fibrous tubular scaffold using a modified wound coil collector and L-shaped ground design for neural repair10.1016/j.msec.2020.110776 ↗
38. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability10.1016/j.jcis.2011.03.071 ↗
39. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/G/PLC/Ca signaling pathways10.1182/blood-2007-11-125203 ↗
40. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins10.1038/ni1013 ↗
41. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice10.1093/emboj/20.6.1223 ↗
42. The effects of the molecular weights of hyaluronic acid on the immune responses10.1186/s40824-021-00228-4 ↗
43. Anti-inflammatory effects of differential molecular weight hyaluronic acids on UVB-induced calprotectin-mediated keratinocyte inflammation10.1016/j.jdermsci.2022.06.001 ↗
44. Different molecular weight hyaluronic acid alleviates inflammation response in DNFB-induced mice atopic dermatitis and LPS-induced RAW 264.7 cells10.1016/j.lfs.2022.120591 ↗
45. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema
46. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation10.1084/jem.20100559 ↗
47. A novel role of Hippo-Yap/TAZ signaling pathway in lymphatic vascular development10.5483/BMBRep.2021.54.6.020 ↗
48. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis10.1016/j.gendis.2019.11.003 ↗
49. Force triggers YAP nuclear entry by regulating transport across nuclear pores10.1016/j.cell.2017.10.008 ↗
50. Nuclear compression regulates YAP spatiotemporal fluctuations in living cells10.1073/pnas.2301285120 ↗
51. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway10.1038/ncomms9357 ↗
52. Interplay between YAP/TAZ and metabolism10.1016/j.cmet.2018.07.010 ↗
53. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers10.1016/j.celrep.2022.111296 ↗
54. The effects of postoperative treadmill exercise on rats with secondary lymphedema10.1371/journal.pone.0285384 ↗
55. Comparison between lymph-specific magnetic resonance lymphangiography (MRL) and near-infrared indocyanine green lymphangiography (NIRF-ICGL) for evaluation of lymphedema
56. Modified mouse models of chronic secondary lymphedema: tail and hind limb models10.1016/j.avsg.2017.01.023 ↗
57. Experimental study of the prevention and treatment of lymphoedema in a rat hindlimb model by applying cardioperitoneal catheters and lacrimal intubation tubes in the inguinoperitoneal region10.1016/j.ejvs.2023.07.001 ↗
58. In vivo dynamic and static analysis of lymphatic dysfunction in lymphedema using near-infrared fluorescence indocyanine green lymphangiography10.1161/ATVBAHA.123.319188 ↗
59. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns10.1097/PRS.0b013e31820cf5df ↗
60. Improved lymphangiogenesis around vascularized lymph node flaps by periodic injection of hyaluronidase in a rodent model
61. A systematic review of indocyanine green lymphography imaging for the diagnosis of primary lymphoedema10.1093/bjr/tqaf006 ↗